Abstract
Cisapride and 5-hydroxytryptamine enhance motility in the canine antrum via separate pathways, not involving 5-hydroxytryptamine1,2,3,4 receptors.
W J de Ridder and J A Schuurkes
Journal of Pharmacology and Experimental Therapeutics January 1993, 264 (1) 79-88;